Cellmid 2018 Annual Report 11
I would like thank our dedicated directors led by our Chairman,
Dr David King, who have given their active support to the
Company. The ever growing Cellmid team; our employees,
consultants and advisers, have been instrumental in getting us
that far. Finally, I would like to thank our shareholders for their
support in the transformational events of capital restructure
and fund raising.
Maria Halasz
CEO and Managing Director
“With a strong balance sheet,
a clinically validated product
portfolio and global distribution
in place, we are well positioned
to take advantage of the positive
tailwind in the anti-aging
consumer market and accelerate
sales growth.”
Maria Halasz
CEO and Managing Director